Results 251 to 260 of about 452,772 (333)
Beyond Ejection Fraction: RV Function and Diastolic Markers as Predictors of Kidney Disease. [PDF]
Pomiato E, Castaldi B, Di Salvo G.
europepmc +1 more source
Using human induced pluripotent stem cells (hiPSCs)‐derived neuronal model, Tian and colleagues reveal that voltage‐gated calcium channels Cav1.2 and Cav1.3, and their mediated calcium ion influx, are essential for early morphogenesis of human neuronal development, while ECEL1 underlies human neuronal functional developmental maturation through CALM3 ...
Yue Tian +5 more
wiley +1 more source
Cardiac Rehabilitation for Heart Failure With Preserved Ejection Fraction: A Narrative Review of the Benefits and Challenges. [PDF]
Alenezi MF +9 more
europepmc +1 more source
Plants are promising materials for building sustainable and eco‐friendly robots due to their inherent multifunctionality, with actuation playing a crucial role. This article focuses on the physical movements of plants and, from the perspective of actuation characteristics, explores representative plant species and their behaviors, the current state of ...
Kazuya Murakami +8 more
wiley +1 more source
Cardiac Magnetic Resonance Imaging in Heart Failure With Preserved Ejection Fraction. [PDF]
Kikuchi DS +5 more
europepmc +1 more source
PEDOT:PSS—A Key Material for Bioelectronics
PEDOT:PSS ‐ Poly(3,4‐ethylenedioxythiophene) polystyrene sulfonate ‐ is typically processed from water dispersions to form multifunctional and multidimensional constructs with tunable electronic and ionic conductivity. Throught processing engineering, PEDOT:PSS is intergrated in bioelectronic devices that operate efficiently in physiological conditions
Alan Eduardo Ávila Ramírez +5 more
wiley +1 more source
Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction? [PDF]
Packer M +5 more
europepmc +1 more source
This study presents an intravesical delivery strategy of ferroptosis‐ and immunity‐inducing nanozyme‐loaded thermoresponsive hydrogels (FMCC@PNH) for enhanced bladder cancer therapy. Abstract Current intravesical therapies for bladder cancer after resection are limited by poor tissue penetration, off‐target effects, and insufficient efficacy.
Yongnan Jiang +11 more
wiley +1 more source

